VisionPoint Advisory Group LLC lessened its holdings in iShares U.S. Medical Devices ETF (NYSEARCA:IHI – Free Report) by 0.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 46,311 shares of the company’s stock after selling 287 shares during the quarter. iShares U.S. Medical Devices ETF accounts for approximately 0.9% of VisionPoint Advisory Group LLC’s investment portfolio, making the stock its 25th biggest position. VisionPoint Advisory Group LLC’s holdings in iShares U.S. Medical Devices ETF were worth $2,701,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Assetmark Inc. lifted its stake in iShares U.S. Medical Devices ETF by 20.7% in the 3rd quarter. Assetmark Inc. now owns 1,615 shares of the company’s stock valued at $96,000 after purchasing an additional 277 shares during the last quarter. Raymond James & Associates lifted its stake in shares of iShares U.S. Medical Devices ETF by 0.5% in the 3rd quarter. Raymond James & Associates now owns 378,727 shares of the company’s stock valued at $22,428,000 after acquiring an additional 1,756 shares during the last quarter. International Assets Investment Management LLC lifted its stake in shares of iShares U.S. Medical Devices ETF by 5,167.0% in the 3rd quarter. International Assets Investment Management LLC now owns 758,814 shares of the company’s stock valued at $44,937,000 after acquiring an additional 744,407 shares during the last quarter. Private Advisor Group LLC boosted its holdings in shares of iShares U.S. Medical Devices ETF by 10.0% during the 3rd quarter. Private Advisor Group LLC now owns 66,263 shares of the company’s stock valued at $3,924,000 after acquiring an additional 6,022 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its position in iShares U.S. Medical Devices ETF by 127.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,202,394 shares of the company’s stock worth $71,206,000 after acquiring an additional 674,168 shares during the last quarter.
iShares U.S. Medical Devices ETF Stock Performance
Shares of IHI stock opened at $64.84 on Friday. The firm has a market capitalization of $6.13 billion, a price-to-earnings ratio of 35.18 and a beta of 0.83. The business’s 50-day moving average price is $61.65 and its 200-day moving average price is $59.84. iShares U.S. Medical Devices ETF has a 12 month low of $53.72 and a 12 month high of $65.18.
About iShares U.S. Medical Devices ETF
The iShares U.S. Medical Devices ETF (IHI) is an exchange-traded fund that is based on the DJ US Select \u002F Medical Equipment index, a market-cap-weighted index of manufacturers and distributors of medical devices in the US. IHI was launched on May 1, 2006 and is managed by BlackRock.
Recommended Stories
- Five stocks we like better than iShares U.S. Medical Devices ETF
- Stock Dividend Cuts Happen Are You Ready?
- These 3 Defensive Retail Stocks Are Outpacing the Market
- Bank Stocks – Best Bank Stocks to Invest In
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- How to Use the MarketBeat Excel Dividend Calculator
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
Want to see what other hedge funds are holding IHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares U.S. Medical Devices ETF (NYSEARCA:IHI – Free Report).
Receive News & Ratings for iShares U.S. Medical Devices ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares U.S. Medical Devices ETF and related companies with MarketBeat.com's FREE daily email newsletter.